ADMA代谢酶基因多态性增加个体罹患心脑血管疾病风险
[Abstract]:In order to investigate the mechanism of ADMA metabolic enzyme gene polymorphism on cardiovascular and cerebrovascular diseases in individuals, 742 patients with coronary heart disease diagnosed by coronary angiography in our hospital from 2012 to 2016 (trial group) were collected. At the same time, 975 healthy volunteers (control group) were collected from the physical examination center of our hospital. Genomic DNA, was extracted from venous blood. PCR and restriction endonuclease method were used to detect the polymorphism of DDAH1 gene locus and the concentration of ADMA by enzyme linked immunosorbent assay (Elisa). The data were statistically analyzed by SPSS15.0 software. The results showed that the CC genotype frequency and C allele frequency of C144563T locus in the trial group were significantly higher than those in the control group, and the difference was statistically significant (p0.05). Logistic regression analysis showed that the frequency of C144563T locus and C allele was significantly higher than that of the control group. Individuals with DDAH1 CC genotype or 144563 C allele had a significantly increased risk of CHD (OR=1.752,p=0.007). The frequency of GC genotype and C allele at C ~ (143611) G locus in the trial group was significantly higher than that in the control group, and the difference was statistically significant (p0.05). Logistic regression analysis showed that the frequency of C ~ (143611) G locus GC genotype and C allele was significantly higher than that of the control group. Individuals with GC genotype or 143611 C allele of DDAH1 gene had a significantly increased risk of CHD (OR=1.890,p=0.004). The average concentration of plasma ADMA in the trial group was (3.07 卤0.51) 渭 mol/mL, significantly higher than that in the control group (1.83 卤0.39) 渭 mol/mL,. The average plasma ADMA concentration of C ~ (144563) T locus CC genotype and C ~ (143611) G GC genotype group was (3.09 卤0.47) 渭 mol/mL,. (3.21 卤0.54) 渭 mol/mL was significantly higher than that of the control group (1.96 卤0.40) 渭 mol/mL, (1.89 卤0.41) 渭 mol/mL, the difference was statistically significant (p0.05). We infer that the C144563 T locus of DDAH1 gene is closely related to C143611 G locus and CHD, and the mechanism may be that the ADMA level is increased by the genotype change of C144563 T locus and C143611 G locus. This leads to the occurrence and development of CHD.
【作者单位】: 重庆市中医院;
【基金】:重庆市中医院资助
【分类号】:R541.4
【相似文献】
相关期刊论文 前10条
1 贺立新;宁阳根;;原发性扩张型心肌病患者内皮功能改变及与ADMA的关系[J];实用预防医学;2008年03期
2 赵雷;张吉凤;赵佳怡;祝金明;李淑梅;;ADMA对人脐静脉内皮细胞粘附功能影响的体外研究[J];中国实验诊断学;2010年02期
3 邓志华;ADMA所致血管内皮功能障碍与心血管疾病[J];江西医药;2004年01期
4 张靓,许豪文,黄叔怀;内源性一氧化氮合酶抑制物:ADMA——新发现的动脉粥样硬化危险因子[J];中国运动医学杂志;2004年01期
5 雅德;;动脉粥样硬化的新标志ADMA[J];国外医学情报;2000年03期
6 高山;朱晓庆;于爽;赵广阳;秦晓玉;;ADMA、白介素—18与冠心病之间的关系以及二者之间相关性研究[J];黑龙江医药科学;2011年01期
7 刘丽梅;潘运波;彭银;;血清ADMA在心力衰竭患者研究中的应用分析[J];中国保健营养;2012年14期
8 贾素洁;姜德建;邓汉武;李元建;;ADMA与动脉粥样硬化研究进展[J];岳阳职业技术学院学报;2006年02期
9 游咏;莫靓;桂庆军;李传昶;杨天伦;;不同程度冠状动脉狭窄患者血清ADMA水平分析[J];山东医药;2010年24期
10 李鑫;蔡久英;占育飞;;高血压病不同左室构型患者血清hs-CRP、ADMA水平变化及意义[J];山东医药;2012年48期
相关会议论文 前2条
1 邓志华;李菊香;罗伟;苏海;程晓曙;吴清华;吴延庆;;氧化损伤血管内皮细胞ADMA代谢机制的研究及卡托普利的作用[A];中华医学会心血管病分会第八次全国心血管病学术会议汇编[C];2004年
2 李菊香;邓志化;苏海;程晓曙;吴清化;罗伟;;卡维地洛对氧化损伤血管内皮细胞ADMA代谢的干预作用[A];中华医学会心血管病分会第八次全国心血管病学术会议汇编[C];2004年
相关博士学位论文 前2条
1 陈美芳;ADMA对内皮损伤和单核细胞活化的影响及机制研究[D];中南大学;2007年
2 朱振东;ADMA在动脉粥样硬化斑块形成中的作用机制研究[D];昆明医学院;2011年
相关硕士学位论文 前6条
1 栾晓琳;AVE3085对ADMA损伤的人冠状动脉内皮细胞的保护作用[D];青岛大学;2016年
2 王建秋;ADMA与高血压、动脉硬化、冠心病关系的临床研究[D];山东大学;2012年
3 蒋新华;ADMA促人脐静脉内皮细胞MMP-9表达及非诺贝特的干预作用[D];中南大学;2008年
4 邓志华;氧化损伤血管内皮细胞ADMA代谢机制的研究及卡维地洛和卡托普利的作用[D];江西医学院;2004年
5 孙宁卫;不对称二甲基精氨酸(ADMA)、高敏C反应蛋白(hs-CRP)与冠脉支架术后再狭窄的相关性研究[D];泰山医学院;2012年
6 朱晓庆;冠心病患者血清IL-18和ADMA浓度的变化及冠心丹参滴丸对其影响的观察[D];佳木斯大学;2011年
,本文编号:2319454
本文链接:https://www.wllwen.com/kejilunwen/jiyingongcheng/2319454.html